Flexion
-
Financial
Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
BURLINGTON, Mass., Nov. 16, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (FLXN) today announced the pricing of an underwritten public…
Read More » -
Financial
Flexion Therapeutics Reports Third Quarter 2016 Financial Results
BURLINGTON, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced financial results for the third quarter…
Read More » -
Extremities
Flexion Therapeutics Announces Appointment of John Magee as Vice President of Sales
BURLINGTON, Mass., Sept. 29, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc.(Nasdaq:FLXN) announced today that it has appointed John Magee as…
Read More » -
Financial
Flexion Therapeutics Reports Second-Quarter 2016 Financial Results
BURLINGTON, Mass., Aug. 03, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced financial results for the second quarter…
Read More » -
Recon
Flexion Therapeutics Adds Three New Executives in Key Roles to Support the Planned Commercial Launch of Zilretta™
BURLINGTON, Mass., July 06, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that three new executives have joined…
Read More » -
Financial
Flexion Therapeutics Announces Proposed Public Offering of Common Stock
BURLINGTON, Mass., June 07, 2016 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten…
Read More »